Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry. Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders. Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015. You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Roddy Boyd is an investigative reporter who has worked for Fortune Magazine, the New York Post, The New York Sun and Institutional Investor News. He also founded The Financial Investigator website, www.thefinancialinvestigator.com. I also wrote "Fatal Risk," on the collapse of AIG.
Most recently, he has founded the Southern Investigative Reporting Foundation, www.sirf-online.org.
SIRF is dedicated to providing document-driven investigative reporting on publicly traded companies. Our work is centered on providing accountability and information to the investing public and regulators. We are organized as a tax-exempt organization, are members of the Investigative News Network and gladly adhere to the highest standards of journalistic integrity. We do not invest in any securities, short or long, and do not take payment for our work. No one sees our work prior to publication.
Dallas currently owns and operates as CEO an Austin-based enterprise consulting firm that specializes in private company lifecycle management, up to and including taking companies public, and in helping consult publicly traded companies ranging in market cap from $100 million to $500 million. He has a specialization in deal flow management and is often the referring and closing source of Joint Ventures and broader M&A. Dallas often works directly with management teams and Boards of microcap and stressed equity companies in which he or members of his professional network are heavily invested. This includes helping with overall strategy, helping with capital structure management, helping facilitate liquidity, helping facilitate Joint Ventures and broader M&A, and helping restructure the business segments if necessary. Recently Dallas has been interviewed by The Pittsburgh Business Times, The Banker, Columbus Business First, Houston Business Journal, The Deal, Energy Intelligence, and his tweets have been used by CNBC to highlight hot button issues regarding Carl Icahn, Bill Ackman, Nelson Peltz’s takeover attempts at DuPont, etc. Dallas has also been quoted and sourced to by StreetSweeper.org, Marcellus.com, MarcellusDrilling.com, Bakken.com, OilOnline.com, and other physical and online publications. "One place of great inefficiency is in the stressed equity markets – or the markets in which a company appears as bankruptcy or a breakup is inevitable. As equities become stressed they often sell down to absurd levels of value that present, should there be value to be unlocked, opportunities for “venture level” returns. These often range in the 3X-10X range. With my unique ability to actually improve business outcomes by working directly with a company and management/Board I’m in a position, should I view the underlying business as salvageable, to directly improve the long-term viability of the company. I am NOT simply an investor in these names but an acting consultant. This allows me to “overlay my network” and to move the company away from a stressed or defaulting outcome and into an outcome probability that allows the equity price to move substantially higher. Identifying these opportunities has generated shareholders and investors thousands of percentage points in aggregate and is something I’m often recognized by paying subscribers for."
Debra Borchardt has worked in all areas of the securities business from mutual funds to trading desks, and even the back office - that's the clearing department for those that don't know. She left the business after getting her Masters degree in Business Journalism from New York University. Debra worked at TheStreet.com for eight years and recently wrote for Stansberry Research newsletters.
Accounting Professor teaching financial accounting; PhD, CPA, CMA, CGMA. He holds a BSBA from the University of Arizona, a Macc. from the University of Arizona, and his PhD from Virginia
Tech. He worked in public accounting, industry, as a CFO, a government auditor for the California Auditor General and in litigation support. His publications have been used and filed in Court proceedings by the Securities and Exchange Commission, he has been quoted in the Wall Street Journal, and his background includes litigation support and expert testimony in cases involving business litigation (e.g., Ford, GM, and so on) in CA, AZ, TX, NV and MN. He enjoys trading stocks and securities, teaching his classes, and publishing in related areas. Also home repair and remodel, snorkling, and cruises to the Carribean.
Douglas H. Leighton
Doug is co-founder and a principal partner of Dutchess Capital, a Boston-headquartered global hedge fund, which has managed an investment portfolio of over $2 billion in transactional value. Doug oversees the fund’s risk management and facilitates all of the fund’s trading on worldwide exchanges. Doug manages deal origination in North America, Europe and Australia and is a member of the firm’s Investment Committee. Douglas has founded several companies and has mentored several startup and growth management teams. He has over two decades of experience in equity trading, investment banking, asset management and the skill set to offer advice to startups and growth companies alike. While the funds are industry agnostic, Douglas has been largely focused on the legal marijuana market for over the past 2 years, initially as an observer while he conducted due diligence for several deals, and now as an active investor and board member for several companies. He also sits on the Company Selection Committee of ArcView, the cannabis angel network as well as a member of the NCIA. Through the Fund and personally, Doug has made numerous investments in ancillary businesses to the cannabis industry, in addition to touching the plant. He is often asked to speak at conferences regarding the business side of the marijuana business. Douglas has held seats on various boards of public and private companies, in addition to serving on the boards of several non-profits.
A full time investor that has a passion for micro cap stocks that looks for undervalued companies for people to invest in. Charts may tell a story but the fundamentals of a company is where the success of the company lies.
Whether you are a large or small firm, GeoInvesting will cater to your needs and create a sound process for corporate diligence. Our specialty is Portfolio Protection – in fact, every aspect of what we do boils down to various ways that your M&A process or investment portfolio can be safeguarded against red flags.
To accomplish this we choose to work closely with you so you can be kept abreast of the progress of our due diligence from start to finish, making sure that we cultivate a relationship of trust between our team and yours.
Who Can We Help Specifically?
We actually do not limit ourselves to any specific group? We have worked at great lengths with:
>High Net Worth Investors
>Private & Public M&A
>Other Due Diligence Firms
There is really no one that we can’t work with since we’ve covered just about every facet of the due diligence process, whether it be on-the-ground or “through the files.” We can even tailor our services to your specific requirements.
We have a retail solution for everyone – the long investor, the short investor, the pump and dump investor and the every day trader that is interested in the micro cap arena. We’ve shown that we can overcome the challenges posed by any market environment, quickly seizing investment and trading opportunities as they arise. Because of this, our Premium members have been able to enjoy above-average returns on our ideas. Our solutions enable us to cater to what matters to you the most.
Do you want access to reports that can convey the proper valuation of equities, reports that can immediately convince the market that these valuations are warranted? Do you want information arbitrage that allows you to be among the first to take action based on the intel? Do you need daily ideas, some of which have proven to be some of the most rewarding calls to action that the GeoTeam has offered? Would you like to follow our GeoBargains and select trades? Or do you just need to be part of an exclusive twitter following that receives alerts before the rest of the market?
If you have answered yes to any of the questions above, then don’t wait any longer. Join our Network and see why our following continues to grow on a daily basis. The faster you join, the more likely you will be among the first to harness the power of our offering.
Sign up today and start to get:
>Daily Trading Ideas
See GeoInvesting Prime on Seeking Alpha Marketplace
My name is Koo Karimi from Riverside, CA.
I am here to seek and learn from the astute and be engaged in active debate about investing in stocks, particular in stock options. Please leave professional and productive commentary when discussing various articles so we can have an effective discussion regarding various investments.
It should be advised that any article material is my own opinions and ideas. Investors should conduct their own due diligence when investing in equities and various trading strategies. I am currently studying security analysis and portfolio management in preparation for the CFA.
Thank you for visiting!
I am a full-time investor. I am fairly knowledgeable about cannabis, the cannabis industry and public companies within, as a result I often like to convey my thoughts and findings. There are many companies that offer high revenue potential, but there are also many companies that are just trying to take advantage of the recent legal cannabis industry emergence. It is important, and this can be somewhat difficult, to "weed out the weeds" and pick the "good ones". I am inspired by critical thoughts, questions and presentation of new information or otherwise overlooked information.
I have been investing privately for ten years. I look to take concentrated positions in stocks with asymmetrical risk/reward profiles. Turn around situations, companies on the verge of significant revenue / EPS growth, and stocks that unjustly sell below their NCAV are all very interesting to me. I find that most of these finds come in small caps, due to their lack of coverage. However I am not averse to taking a position in a large company which I think fits one of my criteria.
Abdalla Al-ayrot is a value investor with a long time horizon. I tend to focus on misunderstood and/or under-followed companies where i believe there are a great amount of value that the market is yet to price in. Some people prefer to buy $1 for 50-60 cents, i usually buy $1 for 20-35 cents.
I have managed money for 5 years, with industry leading results, which i think is a direct result of my extensive and innovative research process.
I have also founded Ayrot, which you can read more about below.
I write about growth industries focusing on their best stock buys on Seeking AlphaConsultant, business management and development.
Former President of Sappanos Decorating Centers, Chicago, with more than 70 employees. Sold in 2010. Sold all our properties in excess of $10m.
Former Research and Teaching Fellow, Harvard and Assoc. Professor Tufts Medical School.
Currently teach business and politics at university in Tel Aviv, write a column for the Jerusalem Post in Business and Finance, and do business management and development consulting to start-ups and struggling companies.
I approach investing as a social theorist and a cultural historian. As a result, I am a contrarian. Studying the history of financialization, I have to agree with value investors like Seth Klarman, George Soros, and John Quiggin that markets are ultimately inefficient. However, I am not an orthodox value-investor. I believe in diversified strategy so as to insure maximum gains while maintaining a "margin of safety." Understanding that markets will operate inefficiently, I sometimes find "playing the greater fool's game" will yield nice short term gains. I have been investing for five years and have had proven results. I offer unique insight on fundamentals that most analysts do not consider.
Cornelius Vanderbilt has done more than any other man to shape our idea of investing. He was the ultimate contrarian. As an investor he looked for both value and risk. His approach to markets is complex and contradictory but can be learned from.
B.A., NYU Gallatin School
M.A. CUNY Gradatuate Center [in progress]
I started a twitter. https://twitter.com/matt_finston
Ph.D in the Faculty of Life Sciences, Bar Ilan University, Israel
Post Doctorate, Weizmann Institute of Science, Israel
Program Manager at Peerion ltd.
publisher of 14 research articles in professional journals.
Junior Staff, Instructor in Academic Courses.
studies in Economics, Israel.
Independent trader and investor over 6 years.
2 years of managing professional investors bio forum in Israel.
2 years at Aradial technologies in. Aradial Converged Billing Software - ARCB - Convergent Billing
I trade mainly on sentiment & leave the more technical aspects to other Wolves, but I do chart. I have a group of traders that pool resources & $$$ to make the #Wolf-Fund. My persona on twitter @wolfofweedstreet only discusses Marijuana related stocks.
I Am the Wolf of Weed Street and while I love profits, I hate scammy companies that trade on over hyped pr's 3x a week and Unicorn farts. I am here to bring balance to the #MMJ universe...But always do your own DD and invest wisely.
Sramana Mitra is the founder of One Million by One Million (1M/1M), a global virtual accelerator that aims to help one million entrepreneurs globally to reach $1 million in revenue and beyond. She is a Silicon Valley entrepreneur and strategy consultant, she writes the blog Sramana Mitra On Strategy, and is author of the Entrepreneur Journeys book series and Vision India 2020. From 2008 to 2010, Mitra was a columnist for Forbes. As an entrepreneur CEO, she ran three companies: DAIS, Intarka, and Uuma. Sramana has a master’s degree in electrical engineering and computer science from the Massachusetts Institute of Technology. Full bio can be found at http://www.sramanamitra.com/bio/
I have been in and out of phot erbb rfmk hemp Cbis mjna for a few years. I've done extensive chart analysis. Interesting findings. Yearly down trend with spikes at beginning of year. Needless to say anybody who has been trading pot sector knows that January 2 that yearly trend reversed to upside. I have always been in at out of small positions but rfmk was cheapest out off all trading in .0002-3 End of year 2013. In at .0006. More at .00014. Accumulated 11 mil in shares. Any body knows rfmk knows that is a hell of a gamble. Then that January trading kicked off. Every body that had a diversified portfolio of pot stocks remembers all those green flashing tickers. I would refresh my balance and it would jump a thousand per click. Rfmk out at .0026'. Gamble paid off. Rfmk had a tell sign if tanking. Mcig. In at .106 Got lucky with that early find. I love the product ordered 2 units to try . Out at .135. Back in at .12 sold half at .15 at other half at .22 back in at .28. Sold Monday at .47 mcig . Got in on hemp at .29 Ouch. Averaged down to .144 with heavy buys at .125 -.13 out at .16 at 10am Tuesday. Scariest trade buying more while your stock tanks. Another gamble payed off. Although hemp has appeal in a billion dollar industry, when asked on Bloomberg about selling of shares, his eyes seemed misleading. I'm no non verbal expert but I used to play alot of holdem at the casino. Eyes are the window to the soul. Bloomberg interview enough to give the stock what it needed to exit position with profit. Every one has tell. So do these stocks. I have been staring at charts all night every night. Which brings me to my google. My apple. My PHOT. In and out since .08 Most recently in at .3989 ouch. Was looking to double tap that 52wk high. That didn't work. You sell off a position and take your profits and get impatient and jump at a peak because a stock you made money off of is showin some good gains. Looking to break out to new highs. Still running off of adrenaline from successful trades. Not paying attention to those tells. Every stock has one. More averaging down to .345 average share Tuesday. With buys at .31 And yet I'm comfortable. I'm happy. My stock is getting cheaper and here I am buying more. PHOT doesn't feel like a gamble. It feels like a good investment. Why. First of all the tells. I told you all I've been doing is analyzing charts. Secondly, how many mj companies have ex CEOs from already successful billion dollar companies. PHOT. If you want a marijuana driven industry, you are gonna need some lights to grow the pot. PHOT. Lastly, phot invests in growing companies in mj sector as well. So you are saying someone out there is investing in pot stocks to make money. What a coincidence, that's what I'm doing. The more money you have to invest the more you can make. Phot has more money than me. There I was at the crack of dawn dumping erbb at .28 on the way up before the epic fall from .31 on another gamble in a shakey pot stock. but no worries now. Back in PHOT. If it goes down more i average down more. Buy more PHOT. If i see a higher ask price during trading day i buy more PHOT. Its weird when ido that. It makes my stock value go up. Weird Concept. If you're interested in my chart findings and tells for PHOT email me. I will have take the time to put together my tells for PHOT and give it to a few of you longs who wish to collaborate on trade ideas. Will be selling at .51 /worst case cenario I will have wait till they release earnings in march. But if I wait that long might as well wait for a dollar. Looking to retest and break .47 by end of month. Expect more consolidation unless pr tommarow. Expect higher low of .29 and lower high of .33 maybe end day at .32 Then again who the hell knows. 81k shares. Long PHOT. Till the next time. I'll be puffing on my mcig analyzing these dam charts growing my money with grow life
My trading experience includes over twenty five years of intense investment analysis, trend analysis and deep level due diligence studies. My interest is to find small company opportunities that have established funding sources, have a plan of action and are in the preliminary to first stages of pipeline development and execution.
My coverage and investment interest includes biotech, small cap and emerging growth companies, regardless of sector.
My goal is to bring exposure to business development companies (BDCs) that finance small to medium sized businesses, typically overlooked by banks. BDCs are an instrument for investors to earn healthy dividends by avoiding double taxation at the corporate level and allowing income to flow directly to each shareholder. Please see website link below for more information.
Darren owns ProActive Financial LLC where he provides Financial Planning and Analysis consulting services. Darren's education includes a Bachelors in Economics, an MBA, and a Certificate in Personal Financial Planning.
Former Silicon Valley test engineer, marketing and market research analyst. Performing stock research, especially on Pink Sheet and OTC stocks, has become somewhat of a hobby for me.
I've been an individual investor since 2000, and generally invest in small cap NASDAQ stocks, with a few NYSE dividend-payers in the mix.
Active investor and trader since my teens. I retired early from my career in healthcare administration and have been a full time investor for 5 years.
I write about 3D Printing Stocks on my site @ 3DPrintingStocks.com, as well as small and microcap stocks (no pinks or junk!) at MicrocapResearch.com
I run a model fund at Ken Kam's Marketocracy, where they do capital management using the best member mutual fund track records with extensive tabulations of alpha, beta, R-squared, and many other fund management evaluations. Marketocracy Capital Management offers SMA (Separately Managed Accounts) through FOLIOfn Institutional ($100,000 minimum accounts) set up to track the top 15 or so long-term track records (many 12 years plus) of the 30000 or so active members that run models at their site. My fund is one of those top models available for SMAs. My SMA investment fund now has a first year performance with double digit alpha. You can see the performance chart at marketocracy.com (the Turtle Fund - symbol BPMF).
My fund methodology is high diversification, usually running around 40-60 stocks from many different sectors. I rarely weight any position much over 5%. I began at Marketocracy developing an analysis method I've labeled The Fractal Base Flow Model. I've been experimenting with variations of my basic methodology with 4 other funds and a 5th where I try new things. With my first and main model fund BPMF (Bruce Pile's Mutual Fund) I did my basic method for the first 7 years or so with an alpha over 30, then strayed a little into other analysis methods that did not work as well. For the SMA, I am using the methods proven to work well.
Marketocracy is a new way of investing that solves a lot of the problems in the industry today. When investors nowadays survey their options, they are perplexed by the mish mash of risk and fees. In mutual funds, you have regulated safety where managers must diversify with less than 10% of your money in any one name in the top of your weightings scheme, making for at least around 20 stocks at any one time. The SEC also prohibits the risk of leverage and investing in dangerous derivatives, etc. But this safety is typically viewed as a tradeoff with performance vs hedge funds, where all the dangerous stuff is allowed. But the sad result of all this danger is that most hedge funds fail. The average life of a hedge fund that makes it past the first year is just 5 years. More than two thirds of all hedge funds that ever existed are now dead. There is the fund of funds option, but the high turnover means that even they must select an all new portfolio of funds about every 5 years. This makes selecting proven long-term performers virtually impossible. A fund of hedge funds will typically not only charge the high hedge fund fees of 1%-4% management fee plus 15%-25% of your returns, but will also charge fees for running the fund of funds. They pile complication upon complication and charge you for it. "Oh, and the hedge fund industry as a whole hasn’t produced alpha/added value to simple portfolios for years, since its assets under management ballooned." [FTalphaville] With typical leverage, that has grown over 15 years from around 20% to over 40% now, you get 40%more risk than mutual fund rules with no significant added performance, just more costs. And because that added leverage risk is so often concentrated in the same areas by all the large funds, inducing systemic risk, when those bets go wrong they can go very wrong. With all the above, an investor must live with the risk of having just one fund manager, or picker of rotating funds in a fund of funds. Imagine a place where you could go to sign up for an account where you could review track records and styles and risk levels of not just one guy, but up to 15 or so, and check on your account signup form how you want to spread your money among these guys. And imagine that all these managers have had to compile top ranked hedge fund performance levels for up to 15 years under the safety level of SEC rules for mutual funds. And imagine you could get all this at roughly cost of a mutual fund. It would be like opening an account and checking the names of Peter Lynch, Warren Buffett, and all your favorite hedge fund managers to gang tackle your investment objectives. And as in any team sport, if one guy hits a cold streak, the others will carry him. No dependence on one manager. Well there is such a place - Marketocracy Capital Management. Here, thousands of people from all walks of life, from retired and active fund managers to ordinary individual investors, compete online with virtual funds. If your track record qualifies, you can open a GIPS account for real money tracking of your model fund and have client accounts track your model. My fund is one of those, ticker BPMF. FOLIOfn Institutional can open a client SMA where you can pick and choose from the best of the best long-term performers. To look into this: Phone: 1-877-462-4180 email: firstname.lastname@example.org web: marketocracy.com